Instituto Valenciano de Oncologia

Valencia, Valencia 46009

1 studies enrolling now · 4 studies all time

What they study most

Advanced Breast Cancer, Bladder Carcinoma in Situ (CIS), Breast Cancer, HER2-negative Breast Cancer, Limited Stage Small Cell Lung Cancer, Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer, PIK3CA Mutation, Small Cell Lung Cancer, Solid Tumor, Adult, Unresectable Solid Tumor

Studies at this site

• First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer — Recruiting now
• Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID) — Running, not enrolling
• Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute) — Running, not enrolling
• Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC) — Running, not enrolling